Citation: Nh. Arden, Control of influenza in the long-term-care facility: A review of established approaches and newer options, INFECT CONT, 21(1), 2000, pp. 59-64
Authors:
Rudenko, LG
Arden, NH
Grigorieva, E
Naychin, A
Rekstin, A
Klimov, AI
Donina, S
Desheva, J
Holman, RC
DeGuzman, A
Cox, NJ
Katz, JM
Citation: Lg. Rudenko et al., Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents, VACCINE, 19(2-3), 2000, pp. 308-318
Authors:
Bridges, CB
Fukuda, K
Holman, RC
De Guzman, AM
Hodder, RA
Gomolin, IH
Galligan, GK
Leib, HB
Gallo, RJ
Regnery, HL
Arden, NH
Cox, NJ
Citation: Cb. Bridges et al., Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996-97, VACCINE, 18(11-12), 2000, pp. 1103-1109
Authors:
Zadeh, MM
Bridges, CB
Thompson, WW
Arden, NH
Fukuda, K
Citation: Mm. Zadeh et al., Influenza outbreak detection and control measures in nursing homes in the United States, J AM GER SO, 48(10), 2000, pp. 1310-1315
Citation: Se. Ohmit et al., Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic, J AM GER SO, 47(2), 1999, pp. 165-171